Gene: ZNF446
Official Full Name: zinc finger protein 446provided by HGNC
Gene Summary: Enables identical protein binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in extracellular space. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12219 | ZNF446 Knockout cell line (HeLa) | Human | ZNF446 | 1:3~1:6 | Negative | Online Inquiry |
KO12220 | ZNF446 Knockout cell line (HCT 116) | Human | ZNF446 | 1:2~1:4 | Negative | Online Inquiry |
KO12221 | ZNF446 Knockout cell line (HEK293) | Human | ZNF446 | 1:3~1:6 | Negative | Online Inquiry |
KO12222 | ZNF446 Knockout cell line (A549) | Human | ZNF446 | 1:3~1:4 | Negative | Online Inquiry |
ZNF446 Gene Knockout Cell Lines represent a pivotal advancement in genetic research, specifically engineered to inactivate the ZNF446 gene, which encodes a zinc-finger protein implicated in transcriptional regulation and various cellular processes. By utilizing CRISPR-Cas9 technology, these cell lines enable precise gene editing, facilitating investigations into the physiological roles of ZNF446, its involvement in disease mechanisms, and regulatory pathways in different cellular contexts.
The knockout mechanism involves the introduction of targeted double-strand breaks in the DNA sequence of the ZNF446 gene, followed by error-prone repair pathways that lead to insertions or deletions (indels) of nucleotides. This results in disrupted gene function, allowing researchers to assess the resulting phenotypic changes. Consequently, these cell lines are invaluable for elucidating pathways related to cell differentiation, proliferation, and apoptosis that are regulated by ZNF446, thereby uncovering potential targets for therapeutic intervention.
Scientifically, ZNF446 Gene Knockout Cell Lines are key tools in both basic research and translational applications. They assist in the investigation of complex diseases such as cancer, metabolic disorders, and neurological conditions, as well as enabling drug discovery initiatives aimed at correcting gene dysfunction or targeting pathways affected by ZNF446. Their ability to provide insights into gene function and contribute to the development of targeted therapies represents a significant contribution to the field.
What sets these knockout cell lines apart from traditional models is their specificity and reliability in genetic modification, combined with high efficiency rates in gene disruption. They are user-friendly, allowing for ease of use in experimental setups, and come with robust validation data to support experimental confidence. Compared with other gene editing technologies, our ZNF446 Gene Knockout Cell Lines offer unparalleled precision and reproducibility, ensuring consistent results across studies.
For researchers and clinicians focused on advancing genetic understanding and therapeutic innovation, our ZNF446 Gene Knockout Cell Lines are not just a product but a gateway to novel discoveries and insights. As a company dedicated to excellence in genetic tools and cellular models, we pride ourselves on delivering high-quality biological products that enhance research efficiency and outcomes in diverse biological fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.